Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENALIDOMIDE for Bone density abnormal: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where LENALIDOMIDE was used for Bone density abnormal.

Most Reported Side Effects for LENALIDOMIDE

Side Effect Reports % Deaths Hosp.
Diarrhoea 27,576 7.9% 545 4,623
Fatigue 22,956 6.6% 444 2,907
Death 19,213 5.5% 19,190 1,415
Off label use 17,017 4.9% 1,252 3,116
Rash 15,794 4.5% 315 1,830
Pneumonia 14,807 4.2% 1,646 11,418
Plasma cell myeloma 14,191 4.1% 5,427 2,477
Neuropathy peripheral 10,215 2.9% 210 988
White blood cell count decreased 9,996 2.9% 176 1,895
Constipation 9,635 2.8% 183 1,395
Nausea 9,206 2.6% 250 1,848
Asthenia 8,192 2.3% 424 2,679
Product dose omission issue 8,145 2.3% 24 691
Platelet count decreased 7,491 2.1% 397 1,855
Neutropenia 6,909 2.0% 670 1,451

Other Indications for LENALIDOMIDE

Plasma cell myeloma (273,951) Product used for unknown indication (20,069) Myelodysplastic syndrome (14,132) Diffuse large b-cell lymphoma (7,858) Off label use (5,767) Plasma cell myeloma in remission (4,678) Follicular lymphoma (3,611) B-cell lymphoma (3,474) Mantle cell lymphoma (2,989) Non-hodgkin's lymphoma (2,744)

Other Drugs Used for Bone density abnormal

DENOSUMAB (621) TERIPARATIDE (139) ALENDRONATE (129) ABALOPARATIDE (70) ZOLEDRONIC ACID (59) RISEDRONATE (47) IBANDRONATE (31) ALENDRONIC ACID (18) ADALIMUMAB (17) ROMOSOZUMAB-AQQG (15)

Related Pages

LENALIDOMIDE Full Profile All Bone density abnormal Drugs LENALIDOMIDE Demographics LENALIDOMIDE Timeline